Showing results (51-60 of 174) with videos related to
Sort By:
Pageof 18
Brain Stimulation|November 1, 2011
Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorderCharles R Conway, Yvette I Sheline, John T Chibnall, et al.Translational Psychiatry|March 25, 2022
No increase in inflammation in late-life major depression screened to exclude physical illnessEline T Luning Prak, Thomas Brooks, Walid Makhoul, et al.Neuroimage|July 9, 2020
Longitudinal ComBat: A method for harmonizing longitudinal multi-scanner imaging dataJoanne C Beer, Nicholas J Tustison, Philip A Cook, et al.The American Journal of Psychiatry|February 3, 2015
Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approachesMary L Phillips, Henry W Chase, Yvette I Sheline, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 18, 2013
Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depressionBrianne M Disabato, Carrie Morris, Jennifer Hranilovich, et al.Journal of Affective Disorders|June 19, 2008
Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depressionChristina L Fales, Deanna M Barch, Melissa M Rundle, et al.Journal of Nuclear Medicine Technology|February 22, 2014
Attenuation Effects of MR Headphones During Brain PET/MR StudiesAaron Ferguson, Jonathan McConathy, Yi Su, et al.Journal of Medicinal Chemistry|June 25, 2005
Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligandsNachwa Jarkas, Jonathan McConathy, Ronald J Voll, et al.Nuclear Medicine and Biology|September 30, 2014
System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acidWeiping Yu, Jonathan McConathy, Jeffrey J Olson, et al.Nuclear Medicine and Molecular Imaging|December 21, 2016
Indeterminate Findings on Oncologic PET/CT: What Difference Does PET/MRI Make?Tyler J Fraum, Kathryn J Fowler, Jonathan McConathy, et al.Pageof 18